Mark Wendel
Vascular & Interventional Radiology · Jonesboro, ARNPI 1659494334
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,099 of the $6,379 with a category attached, or 79.9%. 15 manufacturers reported payments, led by Nevro Corp. at 36.7% of the total.
Across 118 payments — averaging $54.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$2K
- Novavax Inc$875
- Boston Scientific$853
- Stimwave Technologies Incorporated$562
- Si-bone, Inc.$515
- Vertos Medical, Inc.$271
- plus $960 from 9 others
What the payments were for
- Consulting fees$87514%
- Travel & lodging$4056%
- Food & beverage$5,09980%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 76 | $2,343 |
| Novavax Inc | 1 | $875 |
| Boston Scientific | 9 | $853 |
| Stimwave Technologies Incorporated | 5 | $562 |
| Si-bone, Inc. | 6 | $515 |
| Vertos Medical, Inc. | 3 | $271 |
| Medtronic | 4 | $227 |
| GRT US Holding, Inc. | 1 | $160 |
| Curonix LLC | 1 | $142 |
| Globus Medical | 1 | $135 |
| Pacira Therapeutics, Inc. | 4 | $85 |
| Stratus Medical, LLC | 1 | $75 |
| Stryker | 3 | $68 |
| Amgen | 2 | $39 |
| Averitas Pharma Inc. | 1 | $29 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,379 in reported general payments places this provider in the 80th percentile of 41 vascular & interventional radiology providers in Arkansas.
See all vascular & interventional radiology providers in Arkansas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 13 | $455 |
| Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine | 27 | $417 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 23 | $134 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $119 |
| Methylprednisolone | 11 | $84 |
| Alprazolam | 11 | $2 |
Paid to pharmacies, not to this prescriber.
Other vascular & interventional radiology in Jonesboro
- Larry JohnsonJonesboro$1K
- Richard ReinholtzJonesboro$472
- Gary AllenLittle Rock$50K
- Edgar St AmourLittle Rock$28K
- David HeisterLittle Rock$24K
- David HaysLittle Rock$22K
- Blake JacksLittle Rock$13K
- Whitney GoodwinLittle Rock$10K
- Mark MossFayetteville$6K
- Amy BezoldLittle Rock$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.